Cargando…

L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway

BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. The poor prognosis of this disease highlights the urgent need to develop more effective therapies. Activation of the STAT3 represents a potential drug target for pancreatic cancer therapy. Currently, clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Encheng, Yang, Lehe, Xiang, Youqun, Hu, Wanle, Li, Caleb, Lin, Jiayuh, Dai, Xuanxuan, Liang, Guang, Jin, Rong, Zhao, Chengguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868586/ https://www.ncbi.nlm.nih.gov/pubmed/29606890 http://dx.doi.org/10.2147/CMAR.S159090

Ejemplares similares

Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019)

Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2020)

Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis
por: Zheng, Dandan, et al.
Publicado: (2021)

Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway
por: Yang, Lehe, et al.
Publicado: (2020)

Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019)

L61H46 Shows Potent Efficacy Against Human Pancreatic Cancer Through Inhibiting STAT3 Pathway [Erratum]
Publicado: (2019)

Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells
por: Zheng, Hailun, et al.
Publicado: (2017)

Osthole inhibits triple negative breast cancer cells by suppressing STAT3
por: Dai, Xuanxuan, et al.
Publicado: (2018)

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
por: Shi, Lingyi, et al.
Publicado: (2017)

Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
por: Zhuang, Yan, et al.
Publicado: (2019)

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
por: Lin, Shichong, et al.
Publicado: (2019)

Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway
por: Kang, Yanting, et al.
Publicado: (2016)

Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells
por: Zhao, Chengguang, et al.
Publicado: (2015)

Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway
por: Qi, Yufeng, et al.
Publicado: (2023)

Design, Synthesis, And Evaluation Of Cyanopyridines As Anti-Colorectal Cancer Agents Via Inhibiting STAT3 Pathway
por: Xu, Lingyuan, et al.
Publicado: (2019)

Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling
por: Yan, Sunshun, et al.
Publicado: (2023)

Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling
por: Wu, Xiaoqing, et al.
Publicado: (2016)

Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
por: Xie, Xiaona, et al.
Publicado: (2021)

Alterations of STEP46 and STEP61 Expression in the Rat Retina with Age and AMD-Like Retinopathy Development
por: Telegina, Darya V., et al.
Publicado: (2020)

Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer
por: Zhao, Zhucheng, et al.
Publicado: (2022)

Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings
por: Zhu, Jian feng, et al.
Publicado: (2011)

A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
por: Lin, Li, et al.
Publicado: (2010)

XZH-5 Inhibits STAT3 Phosphorylation and Enhances the Cytotoxicity of Chemotherapeutic Drugs in Human Breast and Pancreatic Cancer Cells
por: Liu, Aiguo, et al.
Publicado: (2012)

LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
por: Zuo, Mingxin, et al.
Publicado: (2015)

Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment
por: Lin, Huey-Jen, et al.
Publicado: (2017)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
por: Ball, Sarah, et al.
Publicado: (2011)

Cyr61/CCN1 targets for chemosensitization in pancreatic cancer
por: Banerjee, Snigdha, et al.
Publicado: (2019)

LLL12B, a Novel Small-Molecule STAT3 Inhibitor, Induces Apoptosis and Suppresses Cell Migration and Tumor Growth in Triple-Negative Breast Cancer Cells
por: Pan, Li, et al.
Publicado: (2022)

Bile duct obstruction associated with pancreatitis in 46 dogs
por: Wilkinson, Ashley R., et al.
Publicado: (2020)

A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells
por: Ahmed, Ahmed Abdullah, et al.
Publicado: (2020)

Artesunate shows potent anti-tumor activity in B-cell lymphoma
por: Våtsveen, Thea Kristin, et al.
Publicado: (2018)

Emerging Roles of Ubiquitin-Specific Protease 25 in Diseases
por: Zhu, Wenjing, et al.
Publicado: (2021)

Operation des lignes F61, F61S, F61N ET T8
por: Ferrando, O.
Publicado: (1999)

Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12
por: Bid, Hemant K., et al.
Publicado: (2012)

Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A(1) Antagonists
por: Val, Cristina, et al.
Publicado: (2022)

A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin
por: Zhang, Ruijie, et al.
Publicado: (2021)

Potent NETosis inducers do not show synergistic effects in vitro
por: Pruchniak, Michał P., et al.
Publicado: (2019)

Fungal volatile organic compounds show promise as potent molluscicides
por: Khoja, Salim, et al.
Publicado: (2019)

Plasticity of Drosophila Stat DNA binding shows an evolutionary basis for Stat transcription factor preferences
por: Rivas, María Luisa, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_64hiagiqp598o84javqfijlif4